Stock Down Under

Money-Making Insights On

ASX-Listed Stocks

Recent Articles

Metals Driving

The Metals Driving Australia’s Market in 2026

January 10, 2026

Australia will still be a…

Read More
Patagonia Lithium

Patagonia Lithium (ASX:PL3) Surges 53% on Ameerex Partnership: Is This Lithium Explorer a Buy?

January 10, 2026

Patagonia Lithium Secures Key Partnerships…

Read More
Aristocrat Leisure

Aristocrat Leisure (ASX:ALL) Extends $750m Buyback: Time to Buy Australia’s Gaming Giant?

January 10, 2026

Aristocrat Leisure: A Compelling Investment…

Read More
Karoon Energy

Karoon Energy (ASX:KAR) Rebounds 5%: Buy the Recovery or Wait for Better Entry?

January 10, 2026

Karoon Energy’s 5% Rebound: What’s…

Read More
Rio Tinto

Rio Tinto (ASX:RIO) Drops 6% on Glencore Merger Talks: Is This the Buying Opportunity or a Warning Sign?

January 10, 2026

Rio Tinto and Glencore’s Merger…

Read More
Investors

Australian Investors Assess Emerging Opportunities Across Global Markets

January 9, 2026

Australian investors are increasingly taking…

Read More
Novonix

Novonix (ASX:NVX) Recharges Investor Hype, Is This Stock a Buy?

January 9, 2026

Hot Charge or Overcharged? Novonix…

Read More
MESOBLAST

Mesoblast (ASX:MSB) Delivers 60% Jump in Ryoncil Sales, Strengthening Commercial Momentum

January 9, 2026

Mesoblast Lifts on Ryoncil Growth…

Read More
codan

Codan (ASX:CDA) Takes Off, 30% Rally on Strong Half-Year Update

January 9, 2026

Codan Finds Its Signal Over…

Read More
cochlear

Cochlear (ASX:COH) is still a long term growth story you should listen to

January 9, 2026

Cochlear is one of few…

Read More
Lithium in 2026

Lithium in 2026: Here is Why The Next Bull Market Is Beginning Now, And 5 ASX Lithium Stocks to Consider!

January 9, 2026

Lithium in 2026 could be…

Read More
Duratec

Duratec (ASX: DUR) Surges on AUKUS Contract Progress: Is This Defence Stock a Buy?

January 9, 2026

Duratec Poised for Growth with…

Read More
Monadelphous

Monadelphous (ASX:MND) Hits All-Time High on $535m BHP and Rio Tinto Contracts: Buy or Take Profits?

January 9, 2026

Monadelphous  Hits Record High on…

Read More
Canyon Resources

Canyon Resources (ASX:CAY) Surges 7% as Cameroon Bauxite Mine Nears Production: Time to Buy?

January 9, 2026

Canyon Resources Targets Bauxite Production…

Read More
Ansell

Ansell (ASX:ANN) Drops 6% on CEO Exit: Is This a Buying Opportunity?

January 9, 2026

Is Ansell’s CEO Change a…

Read More
Anthropic

Anthropic Eyes US$10B Raise at US$350B Valuation, Led by GIC and Coatue

January 8, 2026

Anthropic’s Next Act Anthropic is…

Read More
Alcidion

Alcidion (ASX:ALC) Surges 15% After Winning Preferred Supplier Role for A$35M NHS Contract

January 8, 2026

Alcidion Secures Preferred Supplier Status…

Read More
Elsight

Elsight (ASX:ELS) Breaks New Ground, A$682K US Order Marks First Civilian Contract Win

January 8, 2026

From Battlefield to Main Street…

Read More
Why Fast Payments Fail

When “Fast” Breaks: A Simple Explanation of Settlement, Holds, and Delays

January 8, 2026

When people say they want…

Read More
Dogs of the Dow

The Dogs of the Dow (or ASX) Strategy: Should Investors Consider It?

January 8, 2026

As investors consider their strategies…

Read More

Find Us in

Stocks Down Under Analysts delve into a large variety of ASX-listed stocks and sectors.

The Metals Driving Australia’s Market in 2026

By Ujjwal Maheshwari | January 10, 2026

Australia will still be a metals market in 2026; that part is not up for debate. What is changing is which metals genuinely deserve long-term capital and which ones investors are holding out of habit. For ASX investors, the next phase is less about spotting the next boom and more about understanding what still works…

Read More

Patagonia Lithium (ASX:PL3) Surges 53% on Ameerex Partnership: Is This Lithium Explorer a Buy?

By Ujjwal Maheshwari | January 10, 2026

Patagonia Lithium Secures Key Partnerships for Growth Patagonia Lithium (ASX: PL3) surged 53% to A$0.13 on Friday, hitting its highest level in nearly a year after announcing a strategic partnership with US-listed Ameerex Corporation. The deal positions Ameerex to invest in Patagonia’s flagship Formentera lithium project in Argentina, as well as its niobium and rare…

Read More

Aristocrat Leisure (ASX:ALL) Extends $750m Buyback: Time to Buy Australia’s Gaming Giant?

By Ujjwal Maheshwari | January 10, 2026

Aristocrat Leisure: A Compelling Investment Opportunity Aristocrat Leisure (ASX: ALL) rose 1.01% to A$57.22 on Friday after announcing a A$750 million extension to its share buyback program. This brings the total buyback to A$1.5 billion, continuing Aristocrat’s aggressive capital returns strategy. The gaming giant has already bought back A$701.1 million worth of shares since February…

Read More

Karoon Energy (ASX:KAR) Rebounds 5%: Buy the Recovery or Wait for Better Entry?

By Ujjwal Maheshwari | January 10, 2026

Karoon Energy’s 5% Rebound: What’s Behind It? Karoon Energy (ASX: KAR) surged over 5% this week after months of painful declines that saw the stock fall from A$2.17 to around A$1.54. The bounce appears tied to growing optimism around the company’s catalyst-heavy 2026, now under new CEO Carri Lockhart. For investors watching the energy space,…

Read More

Rio Tinto (ASX:RIO) Drops 6% on Glencore Merger Talks: Is This the Buying Opportunity or a Warning Sign?

By Ujjwal Maheshwari | January 10, 2026

Rio Tinto and Glencore’s Merger Proposal Rio Tinto (ASX: RIO) fell over 6 per cent on Friday after Glencore confirmed the two mining giants are in early merger talks. The deal would combine Rio’s A$200 billion market cap with Glencore’s £53 billion to create a resources powerhouse worth roughly US$260 billion in enterprise value. Yet…

Read More

Australian Investors Assess Emerging Opportunities Across Global Markets

By Ujjwal Maheshwari | January 9, 2026

Australian investors are increasingly taking a strategic approach to portfolio construction as global markets evolve and traditional asset correlations shift. With equity valuations under scrutiny, interest rates remaining a key variable, and new financial instruments gaining traction, investors are reassessing where long-term value can be found. Understanding how emerging trends fit within an overall investment…

Read More

Novonix (ASX:NVX) Recharges Investor Hype, Is This Stock a Buy?

By Charlie Youlden | January 9, 2026

Hot Charge or Overcharged? Novonix Soars 34% as Bulls Reconnect Novonix (ASX:NVX) has experienced a sharp sell off in recent months, falling from around A$1.00 in October to approximately A$0.57 today. Like many critical minerals names, sentiment has been weak, but the key trigger for Novonix was the loss of its major supply agreement with…

Read More

Mesoblast (ASX:MSB) Delivers 60% Jump in Ryoncil Sales, Strengthening Commercial Momentum

By Charlie Youlden | January 9, 2026

Mesoblast Lifts on Ryoncil Growth Mesoblast (ASX:MSB) delivered a very strong performance this morning following a positive guidance update for Ryoncil, its cell-based therapy and the only FDA approved treatment for steroid refractory acute graft versus host disease. This is a serious and often life-threatening condition with limited treatment options, which helps explain the growing…

Read More

Codan (ASX:CDA) Takes Off, 30% Rally on Strong Half-Year Update

By Charlie Youlden | January 9, 2026

Codan Finds Its Signal Over the past week, Codan Limited (ASX:CDA) has surged by around 30%. For a company with a market capitalisation above A$5 billion, this represents a meaningful re rating by the market. Today’s trading update helps explain why. Codan reported group revenue of A$394 million, up 29% on the prior period, indicating…

Read More

Cochlear (ASX:COH) is still a long term growth story you should listen to

By Nick Sundich | January 9, 2026

Cochlear is one of few stocks that has created immense shareholder value and has also greatly improved the lives of its users. Yes, this can be said with respect to many ASX health stocks, but this one can hang its hat on its societal impacts more than most other companies. What are the Best ASX…

Read More

Sector Analysis

The-Best-Mining-Stocks

The Best Mining Stocks

Mining and resources stocks have substantial potential given demand for all types of resources and metals from gold and iron ore to battery metals like lithium and graphite! There are over 700 stocks in this sector from big miners to small cap explorers.

The-Best-Tech-Stocks

The Best Tech Stocks

Tech stocks are appetising in the context of an increasingly digital world ranging from data centre builders, cloud services providers and cybersecurity companies. Many of the ASX's best performing stocks in the last decade have been tech stocks.

The-Best-Uranium-Stocks

The Best Uranium Stocks

Uranium stocks are in a good spot right now with rising demand for clean energy, nuclear energy making a comeback and yellowcake pricing reaching levels not seen since the GFC. This has enabled many companies with mothballed projects to bring them out of hibernation.

Untitled design

The Best Healthcare Stocks

There are dozens of Healthcare stocks on the ASX ranging from big names like CSL and Cochlear with established products and markets, to small cap biotechs and medtechs hoping to follow in their footsteps and commercialise the next big innovation.

The-Best-Mining-Stocks

The Best Mining Stocks

The-Best-Tech-Stocks

The Best Tech Stocks

The-Best-Uranium-Stocks

The Best Uranium Stocks

Share Type Analysis

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The quest for the best stocks to buy now is a never-ending one, but armed with a solid investment strategy, you can create a diversified portfolio that stands the test of time. We provide our Top 10 ASX stocks we think investors should consider right now. 

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The Top Penny Stocks

The Top Penny Stocks

Navigating ASX Penny stocks, can be complex, given the diversity of companies operating in various sectors and the high risk associated with them. But there is potential for impressive returns if investors can find the right company.

The Top Penny Stocks

The Top Penny Stocks

The Top Dividend Stocks

The Top Dividend Stocks

Investing in Dividend stocks can provide an additional source of income, and so are popular with a wide variety of investors. But only some companies pay dividends, and even consistent payers can fluctuate payouts year to year. We outline the Top Dividend Stocks for investors to consider.

The Top Dividend Stocks

The Top Dividend Stocks

size set 1

Top ASX Index Funds

Explore our comprehensive analysis of the top ASX index funds, carefully curated by industry experts. Discover which funds are currently outperforming and why, based on detailed market trends and performance metrics. Ideal for both new and seasoned investors seeking strategic investment opportunities on the ASX. Dive into our report today to make informed investment decisions.

size set 1

Top ASX Index Funds

size 2

The Top Blue Chip Stocks

Discover the best ASX blue chip stocks for investment. Our industry experts provide in-depth analysis on these well-established companies with strong credit ratings and a long history of performance and stability. Explore market leaders like Commonwealth Bank of Australia, BHP Group Ltd, and National Australia Bank Limited.

size 2

The Top Blue Chip Stocks

size 3

Top ASX Growth Stocks for Investing

Explore our comprehensive analysis of the top ASX growth stocks for investing. Our industry experts have curated a detailed report on the most promising opportunities available in the market. Whether you're a seasoned investor or just starting out, our insights provide valuable information to help you make informed decisions.

size 3

Top ASX Growth Stocks for Investing

Webinars and Interviews

Weebit Nano signs license deal with Texas Instruments: Interview with CEO Coby Hanoch

Weebit Nano bags an analog elephant We spoke with CEO Coby Hanoch about the license deal…

Chimeric Therapeutics (ASX:CHM) is headed for the CAR-T ‘Big Time’

Chimeric Therapeutics (ASX:CHM) We spoke to Dr Rebecca McQualter, CEO of Chimeric Therapeutics (ASX:CHM), about the…

Alma Metals (ASX:ALM) plans to ride the long term copper wave

Alma Metals (ASX: ALM) We spoke to Dr Frazer Tabeart, CEO of Alma Metals (ASX: ALM),…

WIN Metals’ (ASX:WIN) Radio Gold project is music to our ears!

WIN Metals (ASX:WIN) We spoke to Steve Norregaard, CEO of WIN Metals (ASX:WIN), about the company’s…

Investment Glossary

Small Cap Company

What Is a Small Cap Company? A Complete Guide for Investors

September 24, 2024

Overview of Small Cap Companies…

All Ordinaries Index

What is the All Ordinaries Index and How Does It Work?

September 20, 2024

The All Ordinaries Index, also…

What is Commodity?

What is Commodity? Understanding Commodity Trading

May 23, 2024

Introduction to Commodities Commodities are…

Securities

Overview of Securities in the Australian Financial Market

May 23, 2024

What is a security? Security refers…

IPO

What Is an IPO? Understanding Initial Public Offerings

May 23, 2024

What is IPO? An Initial Public…

The Team Behind Stocks Down Under

1rw

Stuart Roberts

Co-Founder

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research

Marc-circle-300x300_webp

Marc Kennis

Co-Founder

Marc is the co-founder of Stocks Down Under and has 25+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,

The Team Behind Stocks Down Under

STUART ROBERTS

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.

MARC KENNIS

Marc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.

PETER KILBY

Pete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.

Please enter your name.
Please enter a message.